Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Vsee Health (VSEE) EPS (Weighted Average and Diluted) (2023 - 2025)

Vsee Health filings provide 3 years of EPS (Weighted Average and Diluted) readings, the most recent being -$0.31 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) fell 135.23% to -$0.31 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.73, a 75.25% increase, with the full-year FY2025 number at -$0.73, up 87.08% from a year prior.
  • EPS (Weighted Average and Diluted) hit -$0.31 in Q4 2025 for Vsee Health, down from -$0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.88 in Q4 2024 to a low of -$3.58 in Q3 2024.
  • Median EPS (Weighted Average and Diluted) over the past 3 years was -$0.11 (2023), compared with a mean of -$0.35.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 438.46% in 2024, down 17800.0% in 2024.
  • Vsee Health's EPS (Weighted Average and Diluted) stood at -$0.26 in 2023, then skyrocketed by 438.46% to $0.88 in 2024, then crashed by 135.23% to -$0.31 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.31 (Q4 2025), -$0.02 (Q3 2025), and -$0.16 (Q2 2025) per Business Quant data.